IL2RB Remodels the Immune Microenvironment and Promotes the Progression of Esophageal Squamous Cell Carcinoma.
Our findings demonstrate that IL2RB plays a critical role in ESCC progression and immune evasion, suggesting its potential as a therapeutic target. Further studies are warranted to explore the clinical application of IL2RB targeting in ESCC treatment.
Authors
- Yang Cao (ORCID: https://orcid.org/0000-0002-0058-614X)
- Qikun Lv
- Jun Bie (ORCID: https://orcid.org/0000-0002-8296-0544)
- Xuqin Feng
- Juan Qin (ORCID: https://orcid.org/0000-0003-4355-5404)
- Yunxiang Tang (ORCID: https://orcid.org/0000-0002-8226-1778)
- Rui Zhu (ORCID: https://orcid.org/0000-0002-8851-8562)
Institutions
- North Sichuan Medical University (CN)
- Dalian Medical University (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- Chongqing Emergency Medical Center (CN)
- Chongqing Cancer Hospital (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-05-01
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00